2006
DOI: 10.1016/s0168-8278(06)80166-2
|View full text |Cite
|
Sign up to set email alerts
|

165 Evaluation of four prognostic scores in patients with acute-on-chronic liver failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
8
0

Year Published

2006
2006
2015
2015

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 0 publications
0
8
0
Order By: Relevance
“…Six ACLF patients witnessed an upper GI bleed during the study period. The median HVPG in the bleeders (n = 6, 16.8 [13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30] mmHg) was not different than that seen in the non-bleeders (n = 18, 15.8 [12-23.5] mmHg) (P = ns). However, in these six patients, the median grade of varices progressed from baseline 1 (0-2) to 2 (2-3) after follow-up of 3 months (P > 0.05).…”
Section: Clinical Biochemical and Histology Follow-upmentioning
confidence: 99%
“…Six ACLF patients witnessed an upper GI bleed during the study period. The median HVPG in the bleeders (n = 6, 16.8 [13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30] mmHg) was not different than that seen in the non-bleeders (n = 18, 15.8 [12-23.5] mmHg) (P = ns). However, in these six patients, the median grade of varices progressed from baseline 1 (0-2) to 2 (2-3) after follow-up of 3 months (P > 0.05).…”
Section: Clinical Biochemical and Histology Follow-upmentioning
confidence: 99%
“…ACLF has been shown to carry poor prognosis, with an in-hospital mortality ranging from 50% to 66% [2,3]. Several extracorporeal liver support systems have been developed to improve prognosis in acute liver failure as well as ACLF, and in a recent meta-analysis, artificial liver support was shown to reduce mortality in ACLF as compared with standard medical treatment [4].…”
Section: Introductionmentioning
confidence: 99%
“…Hepatitis B virus (HBV)-related ACLF refers to liver failure occurring in patients with HBV related liver diseases including chronic hepatitis B (CHB), liver cirrhosis, or chronic asymptomatic hepatitis B surface antigen carriers (Chinese society of Infectious Diseases and Parasitology and Chinese Society of Hepatology of Chinese Medical Association 2000), which is termed as acute-onchronic hepatitis B liver failure (ACHBLF). ACHBLF has poor prognosis with an in-hospital mortality ranging from 50% to 66% (Sen et al 2004;Stauber et al 2006).…”
mentioning
confidence: 99%